 TUCSON, Ariz., Nov. 23, 2020 GLOBE NEWSWIRE -- HTG Molecular Diagnostics, Inc. Nasdaq: HTGM, a life science company whose mission is to advance precision medicine, today announced that as a result of its one-for-fifteen reverse stock split which became effective at 5:00 p.m. Eastern Time on November 20, 2020, its common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market Nasdaq effective with the open of the market today, Monday, November 23, 2020. HTGs common stock will continue to trade under the ticker symbol HTGM. 